|
Volumn 8, Issue 3, 2007, Pages 223-227
|
T cell recognition of lipids: Quo vadis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD1 ANTIGEN;
CD137 ANTIGEN MONOCLONAL ANTIBODY;
CD40 LIGAND MONOCLONAL ANTIBODY;
CYTOKINE;
DEATH RECEPTOR 5 MONOCLONAL ANTIBODY;
LIPID;
MONOCLONAL ANTIBODY;
SULFATIDE;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
ANTIGEN BINDING;
ANTIGEN PRESENTATION;
ANTIGEN STRUCTURE;
ANTINEOPLASTIC ACTIVITY;
ARTHRITIS;
AUTOIMMUNE DISEASE;
BRONCHUS HYPERREACTIVITY;
CANCER;
CELLULAR IMMUNITY;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
EFFECTOR CELL;
EXPERIMENTAL NEOPLASM;
GENETIC REGULATION;
HUMAN;
IMMUNOPATHOLOGY;
IMMUNOREGULATION;
INSULIN DEPENDENT DIABETES MELLITUS;
LYMPHOCYTE FUNCTION;
LYMPHOCYTOPOIESIS;
NATURAL KILLER T CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN LIPID INTERACTION;
SIGNAL TRANSDUCTION;
TH1 CELL;
TH2 CELL;
ANIMAL;
CYTOTOXIC T LYMPHOCYTE;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
ANIMALS;
ANTIGEN PRESENTATION;
ANTIGENS, CD1;
HUMANS;
LIPIDS;
LYMPHOCYTE ACTIVATION;
T-LYMPHOCYTES, CYTOTOXIC;
|
EID: 34247869112
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni0307-223 Document Type: Conference Paper |
Times cited : (5)
|
References (15)
|